# Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms

> **NCT05945563** · — · UNKNOWN · sponsor: **Methodist Health System** · enrollment: 208 (estimated)

## Conditions studied

- Cerebral Aneurysm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05945563
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-17
- **Primary completion:** 2025-01-17
- **Final completion:** 2025-12-17
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05945563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05945563, "Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05945563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*